BRAF and melanoma: In our study, the combination of S63845 with ABT-263, ABT-737, and ABT-199 showed high efficiency both in BRAF-mutated and BRAF-WT melanoma cell lines, as evidenced by induced apoptosis in up to 94% of the cells and almost complete loss of cell viability.